跳至主要内容
临床试验/ITMCTR2200005935
ITMCTR2200005935尚未招募1 期

Randomized controlled study on the clinical efficacy of Tiaozhi Tongmai granule in the treatment of atherosclerosis

Fangshan Hospital Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
45 至 70(—)
性别
All

入选标准

  • ? Conform to the diagnostic criteria of carotid atherosclerosis;
  • ? Conform to the standard of TCM syndrome differentiation;
  • ? Middle aged and elderly people aged 45-70 (including 45 and 70);
  • ? If you are taking drugs to treat carotid atherosclerosis, you need to stop the drug for more than 4 weeks;
  • ? Sign the informed consent form (see Annex 1) and volunteer to participate in the trial;

排除标准

  • ? combined serious primary diseases such as cardio cerebrovascular, liver, kidney and hematopoietic system;
  • (2) combined type 2 diabetes mellitus with poor glycemic control and glycosylated hemoglobin (HbA1c) is more than 8%.
  • (3)combined type I diabetes mellitus and severe endocrine diseases;
  • ? Coagulation dysfunction, or have been using anticoagulant drugs, such as warfarin and heparin;
  • ? Pregnant or lactating women;
  • ? Patients with mental diseases;
  • ? Patients with acute infectious diseases;
  • ? Patients with malignant tumors.

研究者

发起方
Fangshan Hospital Beijing University of Chinese Medicine

相似试验